Paul Dowling

4.5k total citations
132 papers, 3.4k citations indexed

About

Paul Dowling is a scholar working on Molecular Biology, Cell Biology and Spectroscopy. According to data from OpenAlex, Paul Dowling has authored 132 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 36 papers in Cell Biology and 34 papers in Spectroscopy. Recurrent topics in Paul Dowling's work include Muscle Physiology and Disorders (48 papers), Advanced Proteomics Techniques and Applications (34 papers) and Muscle metabolism and nutrition (22 papers). Paul Dowling is often cited by papers focused on Muscle Physiology and Disorders (48 papers), Advanced Proteomics Techniques and Applications (34 papers) and Muscle metabolism and nutrition (22 papers). Paul Dowling collaborates with scholars based in Ireland, Germany and United States. Paul Dowling's co-authors include Kay Ohlendieck, Martin Clynes, Paula Meleady, Michael Henry, Dieter Swandulla, Philip Doran, Margit Zweyer, Peter O’Gorman, Sandra Murphy and Kevin Culligan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Paul Dowling

128 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Dowling Ireland 35 2.5k 811 613 495 456 132 3.4k
Norie Araki Japan 36 2.1k 0.8× 719 0.9× 530 0.9× 283 0.6× 486 1.1× 102 4.6k
Erik Schaefer United States 41 4.1k 1.6× 1.7k 2.1× 299 0.5× 643 1.3× 1.1k 2.3× 68 6.5k
Michiaki Kohno Japan 35 3.1k 1.2× 523 0.6× 280 0.5× 531 1.1× 846 1.9× 92 4.5k
François Houle Canada 26 3.0k 1.2× 794 1.0× 461 0.8× 616 1.2× 570 1.3× 38 4.1k
Judith A. Coppinger United States 21 1.8k 0.7× 1.1k 1.3× 138 0.2× 249 0.5× 482 1.1× 32 3.1k
Sungyong You United States 33 2.0k 0.8× 419 0.5× 369 0.6× 917 1.9× 566 1.2× 151 4.0k
Nicole M. Verrills Australia 28 1.8k 0.7× 456 0.6× 179 0.3× 357 0.7× 413 0.9× 69 2.7k
Kohji Hanasaki Japan 36 2.5k 1.0× 579 0.7× 533 0.9× 301 0.6× 345 0.8× 83 4.0k
Mariona Graupera Spain 35 2.4k 1.0× 419 0.5× 331 0.5× 546 1.1× 978 2.1× 59 4.6k
Meng‐Ru Shen Taiwan 34 1.9k 0.7× 400 0.5× 256 0.4× 349 0.7× 571 1.3× 86 3.1k

Countries citing papers authored by Paul Dowling

Since Specialization
Citations

This map shows the geographic impact of Paul Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Dowling more than expected).

Fields of papers citing papers by Paul Dowling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Dowling. The network helps show where Paul Dowling may publish in the future.

Co-authorship network of co-authors of Paul Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Dowling. A scholar is included among the top collaborators of Paul Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Dowling. Paul Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowling, Paul, et al.. (2024). In vitro evaluation of the clinical utility of Apitolisib/Vorinostat combination in Apitolisib-resistant H1975 lung adenocarcinoma cells. SHILAP Revista de lepidopterología. 10(1). 1 indexed citations
2.
Dowling, Paul, Capucine Trollet, Elisa Négroni, Dieter Swandulla, & Kay Ohlendieck. (2024). How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?. Proteomes. 12(1). 4–4. 4 indexed citations
3.
Dowling, Paul, Margit Zweyer, Hemmen Sabir, et al.. (2023). Mass spectrometry-based proteomic characterization of the middle-aged mouse brain for animal model research of neuromuscular diseases. European Journal of Translational Myology. 33(3). 2 indexed citations
4.
Katsenou, Angeliki, et al.. (2023). Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach. International Journal of Molecular Sciences. 24(21). 15570–15570. 5 indexed citations
5.
Bazou, Despina, Michael Henry, Paula Meleady, et al.. (2023). Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures. Cancers. 15(15). 3764–3764. 4 indexed citations
6.
Miettinen, Juho J., Romika Kumari, Gunnhildur Ásta Traustadóttir, et al.. (2021). Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen. Cancers. 13(7). 1527–1527. 39 indexed citations
7.
Assis, Leandro José de, Lilian Pereira Silva, Özgür Bayram, et al.. (2021). Carbon Catabolite Repression in Filamentous Fungi Is Regulated by Phosphorylation of the Transcription Factor CreA. mBio. 12(1). 53 indexed citations
8.
Kavanagh, Emma, Melinda Halász, Paul Dowling, et al.. (2020). N -Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny. Molecular Omics. 17(1). 72–85. 14 indexed citations
9.
Dowling, Paul, et al.. (2020). Identification of marker proteins of muscular dystrophy in the urine proteome from the mdx-4cv model of dystrophinopathy. Molecular Omics. 16(3). 268–278. 15 indexed citations
10.
Dowling, Paul, et al.. (2020). Proteomic profiling of fatty acid binding proteins in muscular dystrophy. Expert Review of Proteomics. 17(2). 137–148. 16 indexed citations
11.
Lê, Giao, Jonathan Bones, Mark Coyne, et al.. (2019). Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma. Molecular Omics. 15(1). 7–20. 8 indexed citations
12.
Dowling, Paul, et al.. (2019). Emerging proteomic biomarkers of X-linked muscular dystrophy. Expert Review of Molecular Diagnostics. 19(8). 739–755. 27 indexed citations
13.
Ho, Matthew, Jiye Liu, Alireza Kalbasi, et al.. (2017). Blocking HDAC3 in Bone Marrow Stromal Cells Has Direct Anti-Multiple Myeloma Effect and Modulates T Cell Function. Blood. 130. 4429–4429. 2 indexed citations
14.
Dowling, Paul & Kay Ohlendieck. (2017). DIGE Analysis of Immunodepleted Plasma. Methods in molecular biology. 1664. 245–257. 5 indexed citations
15.
Henry, Michael, Justine Meiller, Annemarie Larkin, et al.. (2017). Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients. SHILAP Revista de lepidopterología. 8. 28–34. 17 indexed citations
16.
Dowling, Paul, Annemarie Larkin, Michael Henry, et al.. (2014). Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Molecular BioSystems. 11(3). 743–752. 26 indexed citations
17.
Dowling, Paul, Ashling Holland, & Kay Ohlendieck. (2014). Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies. Journal of Neuromuscular Diseases. 1(1). 15–40. 23 indexed citations
18.
Dowling, Paul, et al.. (2013). Naturally Protected Muscle Phenotypes: Development of Novel Treatment Strategies for Duchenne Muscular Dystrophy. MURAL - Maynooth University Research Archive Library (National University of Ireland, Maynooth). 1 indexed citations
19.
Rajpal, Rajesh K., Paul Dowling, Justine Meiller, et al.. (2011). A novel panel of protein biomarkers for predicting response to thalidomide‐based therapy in newly diagnosed multiple myeloma patients. PROTEOMICS - CLINICAL APPLICATIONS. 5(9-10). 551–551. 3 indexed citations
20.
Dowling, Paul, Lorraine O’Driscoll, Paula Meleady, et al.. (2007). 2‐D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis. 28(23). 4302–4310. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norie Araki Breakdown of academic impact, for papers by Erik Schaefer Breakdown of academic impact, for papers by Michiaki Kohno Breakdown of academic impact, for papers by François Houle Breakdown of academic impact, for papers by Judith A. Coppinger Breakdown of academic impact, for papers by Sungyong You Breakdown of academic impact, for papers by Nicole M. Verrills Breakdown of academic impact, for papers by Kohji Hanasaki Breakdown of academic impact, for papers by Mariona Graupera Breakdown of academic impact, for papers by Meng‐Ru Shen
Rankless by CCL
2026